BioNJ’s CEO Summit
Industry’s New World Order and Implications for Innovation:
Unprecedented Challenges/Unparalleled Opportunities
With Insights from McKinsey & Company
October 27, 2017
7:00 a.m. – 4:00 p.m.
Bridgewater Marriot | Bridgewater, NJ
Join us for BioNJ’s Fifth Annual CEO Summit, Friday, October 27, 2017 at the Bridgewater Marriott. The CEO Summit will bring together more than 300 life sciences C-suite leaders and their teams — representing a wide breadth of companies from early to late stage, as well as public, private, revenue and pre-revenue enterprises — for a full-day program focused on the opportunities and challenges facing the sector as it works to bring innovative medicines to market to address unmet medical needs.
Our unprecedented roster of speakers — all world-class leaders at the forefront of this vital topic — will deliver insights on fostering medical innovation amid continual change and uncertainty.
Mark Alles, CEO, Celgene Corporation
Albert Bourla, Group President, Pfizer Innovative Health, Pfizer Inc.
Elizabeth Fowler, Ph.D., JD, Vice President, Global Health Policy, Johnson & Johnson
James Greenwood, President & CEO, Biotechnology Innovation Organization
Paul Hudson, CEO, Novartis Pharmaceuticals
Clive Meanwell, M.D., Ph.D., CEO, The Medicines Company
Brent Saunders, CEO, Allergan
Join fellow executives, investors, entrepreneurs, academics and other members of New Jersey’s robust life sciences community for a day of learning and networking. The dynamic list of topics includes:
- An Industry Innovation Update
- Innovation Threats and Opportunities
- Emerging Companies on the Move
- Innovation, Politics and the Journey to Market
- Navigating the Unknown
- The Patient in the Process
- The Regulatory Horizon
Registration for the event is $595 for Members of BioNJ and affiliated organizations and $795 for future BioNJ Members. Contact Edie Esposito at EEsposito@BioNJ.org to learn about Sponsorship opportunities and place your company in the spotlight.